News Image

Investors should take note of NASDAQ:CORT, a growth stock that remains attractively priced.

By Mill Chart

Last update: Dec 20, 2024

Our stock screener has spotted CORCEPT THERAPEUTICS INC (NASDAQ:CORT) as a growth stock which is not overvalued. NASDAQ:CORT is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced. We'll dive into each aspect below.


Affordable Growth stocks image

A Closer Look at Growth for NASDAQ:CORT

ChartMill assigns a proprietary Growth Rating to each stock. The score is computed by evaluating various growth aspects, like EPS and revenue growth. We take into account the history as well as the estimated future numbers. NASDAQ:CORT was assigned a score of 9 for growth:

  • The Earnings Per Share has grown by an impressive 55.56% over the past year.
  • CORT shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.65%.
  • Measured over the past years, CORT shows a quite strong growth in Revenue. The Revenue has been growing by 13.94% on average per year.
  • CORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.09% yearly.
  • CORT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.39% yearly.
  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Valuation Insights: NASDAQ:CORT

ChartMill assigns a Valuation Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing different valuation elements, such as price to earnings and free cash flow, both in absolute terms and relative to the market and industry. In the case of NASDAQ:CORT, the assigned 6 reflects its valuation:

  • CORT's Price/Earnings ratio is rather cheap when compared to the industry. CORT is cheaper than 80.10% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CORT indicates a somewhat cheap valuation: CORT is cheaper than 76.44% of the companies listed in the same industry.
  • Based on the Enterprise Value to EBITDA ratio, CORT is valued a bit cheaper than 79.06% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CORT is valued cheaply inside the industry as 80.10% of the companies are valued more expensively.
  • CORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CORT may justify a higher PE ratio.
  • A more expensive valuation may be justified as CORT's earnings are expected to grow with 59.58% in the coming years.

Assessing Health Metrics for NASDAQ:CORT

ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. NASDAQ:CORT was assigned a score of 9 for health:

  • An Altman-Z score of 24.95 indicates that CORT is not in any danger for bankruptcy at the moment.
  • CORT's Altman-Z score of 24.95 is amongst the best of the industry. CORT outperforms 92.15% of its industry peers.
  • CORT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • CORT has a Current Ratio of 3.70. This indicates that CORT is financially healthy and has no problem in meeting its short term obligations.
  • CORT has a Quick Ratio of 3.64. This indicates that CORT is financially healthy and has no problem in meeting its short term obligations.

A Closer Look at Profitability for NASDAQ:CORT

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:CORT has achieved a 7:

  • CORT has a Return On Assets of 18.08%. This is amongst the best in the industry. CORT outperforms 97.91% of its industry peers.
  • With an excellent Return On Equity value of 22.20%, CORT belongs to the best of the industry, outperforming 94.24% of the companies in the same industry.
  • CORT's Return On Invested Capital of 18.79% is amongst the best of the industry. CORT outperforms 94.76% of its industry peers.
  • CORT has a better Profit Margin (22.56%) than 94.76% of its industry peers.
  • Looking at the Operating Margin, with a value of 22.81%, CORT belongs to the top of the industry, outperforming 89.53% of the companies in the same industry.
  • CORT has a better Gross Margin (98.44%) than 98.43% of its industry peers.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

Our latest full fundamental report of CORT contains the most current fundamental analsysis.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

CORCEPT THERAPEUTICS INC

NASDAQ:CORT (12/19/2024, 8:25:40 PM)

After market: 51.15 0 (0%)

51.15

-1.27 (-2.42%)

Follow us for more